Strontium ranelate, a therapeutic for osteoporosis, was thought to have a dual mode of action, simultaneously stimulating bone formation and reducing resorption. A recent study casts doubt on this explanation, suggesting instead that it has a mild suppressive effect on bone formation with little effect on bone resorption.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/nrendo.2013.210 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!